Live from the NIH registry
Studies recruiting near Nashua right now
Top 25 of 254 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: AB Science
Collection and Distribution of Biospecimens for Novel Research Uses
Cancer, Healthy
N/A
Observational 10,000 participants sought
iSpecimen — Lexington, Massachusetts (24.9 mi)
· Sponsor: iSpecimen Inc
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Dartmouth Cancer Center - Nashua — Nashua, New Hampshire (1.6 mi)
· Sponsor: SWOG Cancer Research Network
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
MedVadis Research Corporation, LLC — Waltham, Massachusetts (28.8 mi)
· Sponsor: Kallyope Inc.
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Tufts Medical Center Cancer Center Stoneham — Stoneham, Massachusetts (27.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Prediction Augmented Screening Initiative
Lung Cancer, Lung Cancer Screening
N/A
Interventional 23,520 participants sought
VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts (20.9 mi)
· Sponsor: VA Office of Research and Development
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Healthy Perspectives - Innovate Mental Health Services /ID# 270847 — Nashua, New Hampshire (1.6 mi)
· Sponsor: AbbVie
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Inflammatory Bowel Syndrome
N/A
Observational 220 participants sought
ALPCO — Salem, New Hampshire (15.0 mi)
· Sponsor: American Laboratory Products Company
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Gastrointestinal Cancer, Hematologic Cancer
N/A
Interventional 210 participants sought
Dana-Farber Cancer Instiute - Merrimack Valley — Methuen, Massachusetts (15.3 mi)
· Sponsor: Nadine McCleary, MD, MPH
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Schizophrenia, Autism-Related Irritability
Phase 3
Interventional 400 participants sought
Local Institution - 0132 — Lexington, Massachusetts (24.9 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
Diabetes Mellitus, Hypertension
N/A
Interventional 1,022 participants sought
Dartmouth Hitchcock Clinics Manchester — Manchester, New Hampshire (17.1 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
MedVadis Research, Merz Investigational Site #0010524 — Waltham, Massachusetts (28.8 mi)
· Sponsor: Merz Therapeutics GmbH
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
MedVadis Research Corporation — Waltham, Massachusetts (28.8 mi)
· Sponsor: Eli Lilly and Company
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung Disease, Common Variable Immunodeficiency
Phase 2
Interventional 38 participants sought
Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
BostonGene-Integrated Genomic Registry (BIGR)
Malignancy
N/A
Observational 100,000 participants sought
BostonGene — Waltham, Massachusetts (28.8 mi)
· Sponsor: BostonGene
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
Bipolar Disorder, Bipolar Disorder Type 1
N/A
Interventional 100 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Stony Brook University
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: PPD Development, LP
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0307 - Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
Lahey Hospital & Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: Eli Lilly and Company
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
MedVadis Research — Waltham, Massachusetts (28.8 mi)
· Sponsor: Crystalys Therapeutics
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
Lowell General Hosptial — Lowell, Massachusetts (11.9 mi)
· Sponsor: PrECOG, LLC.
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
Periodontal Diseases, Periodontitis
N/A
Interventional 70 participants sought
Acton Dental Associates — Acton, Massachusetts (18.5 mi)
· Sponsor: Erchonia Corporation
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Phase 3
Interventional 718 participants sought
Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: SWOG Cancer Research Network
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
MedVadis Research Watertown — Waltham, Massachusetts (28.8 mi)
· Sponsor: Novo Nordisk A/S
Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis
Multiple Sclerosis, Fatigue
N/A
Interventional 2,000 participants sought
iConquerMS — Waltham, Massachusetts (28.8 mi)
· Sponsor: Accelerated Cure Project for Multiple Sclerosis